ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OXB Oxford Biomedica Plc

328.00
28.00 (9.33%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biomedica Plc LSE:OXB London Ordinary Share GB00BDFBVT43 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  28.00 9.33% 328.00 325.50 330.00 350.00 303.00 304.00 1,285,192 16:35:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medicinal Chems,botanicl Pds 139.99M -45.16M -0.4676 -6.95 313.89M

Oxford Biomedica PLC Holding(s) in Company (2758N)

28/09/2021 4:48pm

UK Regulatory


Oxford Biomedica (LSE:OXB)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Oxford Biomedica Charts.

TIDMOXB

RNS Number : 2758N

Oxford Biomedica PLC

28 September 2021

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0006648157

Issuer Name

Oxford Biomedica plc

UK or Non-UK Issuer

UK

2. Reason for Notification

Other

Comments

Due to increased number of shares issued to the Serum Life Sciences

3. Details of person subject to the notification obligation

Name

Vulpes Investment Management Pte Ltd

City of registered office (if applicable)

SG

Country of registered office (if applicable)

Singapore

4. Details of the shareholder

 
  Name                          City of registered office    Country of registered office 
   Vulpes Testudo Fund                                        Cayman Islands 
                              ===========================  ============================== 
   Vulpes Life Sciences Fund                                  Cayman Islands 
                              ===========================  ============================== 
 

5. Date on which the threshold was crossed or reached

28-Sep-2021

6. Date on which Issuer notified

28-Sep-2021

7. Total positions of person(s) subject to the notification obligation

 
                          % of voting rights      % of voting rights      Total of both in %      Total number of 
                          attached to shares      through financial       (8.A + 8.B)             voting rights held 
                          (total of 8.A)          instruments (total                              in issuer 
                                                  of 8.B 1 + 8.B 2) 
   Resulting situation 
    on the date on 
    which threshold 
    was crossed or 
    reached                10.640000               0.000000                10.640000               9159254 
                        ======================  ======================  ======================  ====================== 
   Position of 
    previous 
    notification (if 
    applicable)            11.950000               0.000000                11.950000 
                        ======================  ======================  ======================  ====================== 
 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

 
Class/Type of shares    Number of direct        Number of indirect      % of direct voting      % of indirect voting 
ISIN code(if possible)  voting rights (DTR5.1)  voting rights           rights (DTR5.1)         rights (DTR5.2.1) 
                                                (DTR5.2.1) 
GB0006648157               9159254                                         10.640000 
                        ======================  ======================  ======================  ====================== 
Sub Total 8.A              9159254                                         10.640000% 
                        ==============================================  ============================================== 
 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 
Type of financial           Expiration date  Exercise/conversion period  Number of voting rights    % of voting rights 
instrument                                                               that may be acquired if 
                                                                         the instrument is 
                                                                         exercised/converted 
 
Sub Total 8.B1 
                            ===========================================  =========================  ================== 
 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

 
Type of financial   Expiration date  Exercise/conversion  Physical or cash     Number of voting     % of voting rights 
instrument                           period               settlement           rights 
 
Sub Total 8.B2 
                    =========================================================  ===================  ================== 
 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

 
Ultimate controlling    Name of controlled      % of voting rights if   % of voting rights      Total of both if it 
person                  undertaking             it equals or is higher  through financial       equals or is higher 
                                                than the notifiable     instruments if it       than the notifiable 
                                                threshold               equals or is higher     threshold 
                                                                        than the notifiable 
                                                                        threshold 
 
 

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

28-Sep-2021

13. Place Of Completion

London, UK

 
 Contact name:        Natalie Walter 
 Contact telephone 
  number:             01865 783000 
                     --------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLUWSVRANUKUAR

(END) Dow Jones Newswires

September 28, 2021 11:48 ET (15:48 GMT)

1 Year Oxford Biomedica Chart

1 Year Oxford Biomedica Chart

1 Month Oxford Biomedica Chart

1 Month Oxford Biomedica Chart

Your Recent History

Delayed Upgrade Clock